Ask HopeStage to help me review this study
This record does not confirm open recruitment. We can help you understand it and explore other studies.
Study ID: NCT00437099. We help you review the study, but cannot decide medical eligibility.
UnknownNCT00437099
Efficacy of Omega-3 Fatty Acids on Borderline Personality Disorder: a Double Blind study.
This study has an unknown status in Spain. It is testing omacor® for Borderline Personality Disorder..
Personality disorders, Borderline personalityDrugFrom 18 Years to 65 Years
Understand this study
Who could participate?
Listed age limits: 18 years to 65 years.
- Listed locations
- Barcelona, SpainSee all locations and recruitment
Compensation and expense reimbursement have not been verified for this summary.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateFebruary 2009
- Recruitment status
- Unknown
- Enrollment listed in the registry
- 102
- Sponsor
- Hospital Universitari Vall d'Hebron Research Institute
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- Spain
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT00437099
- Official title
- Efficacy of Omega-3 Fatty Acids on Borderline Personality Disorder: a Randomized, Double Blind Clinical Trial.
Recruitment & locations
Status unknownBarcelona
Registry details
Registry conditions (original wording)
Borderline Personality Disorder.
A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is Hospital Universitari Vall d'Hebron Research Institute, a hospital or academic medical center.
Does this study involve medication?
Yes. The study involves medication, including Omacor® and Placebo.
Who can participate?
Listed age limits: 18 years to 65 years.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit meExplore related studies
Other studies that may be relevant based on condition, country, or study type.
UnknownNCT02752503
Nalmefene in Alcohol Dependence and Borderline Personality Disorder
This study has public registry information. It focuses on personality disorders and currently lists study information in Spain.
UnknownNCT04160871
"Family Connections": a Program for Relatives of People With Borderline Personality Disorder
This study has public registry information. It focuses on personality disorders and currently lists study information in Spain.
UnknownNCT05215392
A Smartphone Application of "Family Connections" to Relatives of People With Borderline Personality Disorder.
This study has public registry information. It focuses on personality disorders and currently lists study information in Spain.